Evidence map›Paper›PMID 22349693›Full record

ReviewChromosoma2012

Inner workings and regulatory inputs that control Polycomb repressive complex 2.

M Maggie O'Meara, Jeffrey A Simon

Registry-linked trialAbstract readReview
In one paragraph

Review in Chromosoma, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03707782 (Mechanisms of Immune Deficiency), which is not on this map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03707782 unknown statusnot on this mapstarted 2020, after this paper: background citation

Mechanisms of Immune Deficiency

TypeobservationalSponsorUniversity of Colorado, DenverRan2020 to 2023Enrolled200ConditionsImmune Deficiency
3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Reprogramming Müller Glia to Regenerate Retinal Neurons.Annual review of vision science · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M Maggie O'MearaDepartment of Genetics, Cell Biology and Development, University of Minnesota, 321 Church St. SE, Minneapolis, MN, 55455, USA.
Jeffrey A Simon

Funding

TRANSCRIPTIONAL REPRESSION BY POLYCOMB GROUP PRODUCTSR01GM049850 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SIMON, JEFFREY A · 1996 to 2017
$4.8M
Control and Function of Histone Methylation in Drosophila Polycomb SilencingF32GM097790 · NIGMS · UNIVERSITY OF MINNESOTA · PI O'MEARA, MICHELLE MARGARET · 2011 to 2013
$155k
NIGMS NIH HHS F32 GM097790NIGMS NIH HHS R01 GM049850
6 · The paper itself

Abstract

Polycomb repressive complex 2 (PRC2) is a conserved multisubunit enzyme that methylates histone H3 on lysine-27. This chromatin modification is a hallmark of target genes transcriptionally silenced by the Polycomb system. At its core, PRC2 activity depends upon the SET domain active site of its catalytic subunit, EZH2, as well as critical stimulatory inputs from noncatalytic subunits, especially EED and SU(Z)12. We review recent progress on this core PRC2 machinery, including key features of the active site, control mechanisms that operate via EZH2 phosphorylation, and subunit elements and architectures that influence PRC2 function. Among these, we highlight work identifying an EED regulatory site that enables PRC2 to bind pre-existing methylated H3-K27 and stimulate enzyme output. These advances illuminate basic inner workings of PRC2 and also provide insights that could aid design of PRC2 inhibitors. The chromatin landscape that PRC2 encounters in vivo is decorated with many histone modifications that accompany active transcription, such as H3-K4 methylation. It has long been assumed that these "active" modifications oppose PRC2 at some level but, until recently, mechanisms of this antagonistic cross-talk have been elusive. We discuss new findings that illuminate how H3-K4 and H3-K36 methylation, H3-K27 acetylation, and H3-S28 phosphorylation each exert a negative impact on PRC2 function. The emerging picture presents PRC2 as a cooperative multipart machine, intricately outfitted to sense and respond to the local chromatin environment and other cues. This PRC2 design ensures flexibility and fine tuning of its fundamental gene silencing roles in diverse biological contexts.

Indexed as

AcetylationAnimalsCatalytic DomainChromatin Assembly and DisassemblyCyclin-Dependent KinasesDNA-Binding ProteinsDrosophila melanogasterDrosophila ProteinsEnhancer of Zeste Homolog 2 ProteinGene Expression RegulationHistone-Lysine N-MethyltransferaseHistonesHumansMethylationNuclear Proteinsp38 Mitogen-Activated Protein KinasesCyclin-Dependent KinasesDNA-Binding ProteinsDrosophila ProteinsEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanE(z) protein, DrosophilaHistone-Lysine N-MethyltransferaseHistonesNuclear Proteinsp38 Mitogen-Activated Protein KinasesPolycomb-Group ProteinsPolycomb Repressive Complex 2PRC2 protein, DrosophilaProtein SubunitsRepressor ProteinsTranscription FactorsTyrosine

Identifiers

PMID22349693
PMCPMC3351537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.